Daewon Pharm, established in 1958, specializes in manufacturing prescription drugs (Finished Products). It is especially strong in R&D focusing on NCE and IMD. In 2013, Daewon recorded 160 Million USD of total sales turnover. Daewon is exporting its ETC and OTC products over 30 countries including emerging markets such as China and Russia. Our team is dedicated to supporting our partners in every aspect. Daewon's representative products are as follows: Pelubi Tab (Pelubiprofen, NCE, NSAID Type), Megex-I ES Susp (Megestrol Acetate), Wontran ER Tab. (Acetaminophen + Tramadol), Oramin-F Cap. (Multi-vitamin + Korean Ginseng), and Propofol MCT-LCT Inj.
Since its establishment
in 1945, Daewoong Pharmaceutical has grown to become one of the top 5
pharmaceutical companies in Korea. With its strong and competent in-house
R&D and qualified manufacturing facilities (cGMP), Daewoong provides a
total healthcare solution to patients across the globe. We manufacture various products (ETC&OTC) including Biologic, Chemical, Medical Device, etc.
Products: Finished Dosage Formulations (Biologic & Chemical), APIs, Antibiotics, Enzymes
Interests: In-licencing, Out-licensing, CDMO
7 Manufacturing Sites (3 Overseas, 4 Korea)
6 Billion Units manufactured annually
Exporting to 90 Countries
70 Years of Experience
3 Overseas R&D centers
8 Global Sales Networks (Branch & Corporation)
770+ Employees working in R&D and Manufacturing (CDMO related) area
678 Drug Approvals up to date
With over 80 years of experience in fluorine research and development, Daikin Chemicals is one of the world's leading manufacturers of fluorochemical products today and committed to innovation in the field. Daikin produces and offers a wide range of intermediates and a series of fluorinating agents, e.g. HFA - Solkane propellants for use in inhalation sprays, as well as custom synthesis of a variety of organic compounds. Daikin's commitment has always been to meet customers' existing and future needs along with providing precise technical service tailored to a customer's specific requirements.
DALCHEM specializes in the synthesis of Phosphine Ligands and Intermediates. Phosphines, Chiral Phosphine Ligands, Diaryl(alkyl)chloro Phosphines are produced in lab, kilo-lab and multi kilo quantities (up to 1000 kg/year). Production capacities are based on usage of 65 lt. Stainless steel reactors (25 pcs. ). DALCHEM provides also Custom Synthesis. Each chemical produced by DALCHEM passes the Quality Control, based on H1 & P31 NMR, HPLC, GC, C&H Analysis and Optical Rotation measurements.
We are mainly engaged in process development of fine chemicals such as Agrochemicals, pharmaceutical intermediates, etc. Dalian Join King has established world class proprietary technology platforms based on core technologies such as heterocycles, chiral chemistry and semi-synthesis, who has been in cooperation with many top 500 companies such as DOW, DuPont, Bayer, FMC, Ella Lilly, DSM and so on, established strategic partnerships and provided them with CRO, CMO services and custom manufacturing service.
Dalian Sky Chemical Co., Ltd was founded in 2003, therefore we began in 1992. Company is mainly engaged in four categories of products: plant extracts, chemical raw materials, finished drug and API. Company only supply high-quality products along with perfect service and fair price to meet customer needs. Based on business development and international changes, the company is also registered with Hong Kong Sky Industry Group Ltd. We are sincerely willing to cooperate with the business elite around the world and create a better future together.
Dara Pharmaceutical Packaging provides to the pharmaceutical, biotech and cosmetic industries the most advanced technological equipment in the market. We offer a high level of innovation and development along with the capability to adapt our knowledge and research to the needs of our customers and to the most demanding international regulations of the sector. We manufacture washing, sterilizing, filling and closing machines for bottles, vials, cartridges, syringes, and bags to process liquid, semi-solid products, and powder in sterile conditions. The machines can work either individually or form a complete production line; can operate under LAF or be integrated into containment systems.
Darbox has a worldwide reputation for over 50 years of excellence in the design, development, production and supply of innovative packaging. Clients include leading companies in the pharmaceutical, chemical, cosmetics, intermediates, excipients and other ingredients industries. Darbox focuses on eco-friendly, HDPE/PP plastic, open-top, stackable, nestable, heavy-duty and UN-certified packaging containers from 10-120L for the transportation and storage of solid and semi-solid dangerous and high-value goods (APIs, powders, tablets, pastes, capsules). We are ISO 9001:HACCP-certified.
Dasan Medichem Co., Ltd. is a specialty drug delivery company developing, manufacturing and marketing technically enhanced APIs, semi-formulation products as well as developing custom formulation and manufacturing for insoluble molecules, sustained release (controlled release) pellets, etc.
1. Oral Finished Dosage form business : tablet / pellet / micro-capsulated powder
With our own micro-particle coating technology and oral delivery system technology,
we furnish product development, technical transfer, and manufacturing.
2. API Chemical Synthesis business
With our own non-infringe patent and technically advanced technology for API synthesis,
we furnish product development, technical transfer and manufacturing.
Datwyler Sealing Solutions is a leading industrial supplier and a key player in the global health care world. Our state-of-the-art solutions for drug packaging and medical devices, build on over 100 years of experience. Within our health care offering, we provide a unique range of products and services including the most advanced elastomer formulations, coatings, aluminum seals, and processing technologies. Partnering up with the world's top pharmaceutical and medical companies, we are a vital link and stand by our mission to ensure all patient's safety and improve patients' lives.
DCS PHARMA: YOUR EXPERT SPECIALISTS FOR ACTIVE PHARMACEUTICAL INGREDIENTS The highest quality, specialized knowledge, and transparency: this is what we bring to active pharmaceutical ingredients. We are your specialists with clearly-defined schedules, extensive high-quality Swiss services, and a global network built up over decades. We focus on a few select therapeutic groups and set the right priorities. Because we're quality-conscious.
Decens Biological Technology Co Ltd specializes in APIs, fine chemical R&D, production and API-marketing. Our major products are 8- Hydrioxyquinolones derivatives and other fine chemical products. Halquinol has acquired property rights. We are certificated by ISO9001: 2008 system. In 2013, we renovated all company equipment and introduced GMP system.
Delmar, a Holding F.I.S. company, specializes in custom cGMP synthesis of APIs and advanced intermediates. Delmar has well-equipped Process R&D and Analytical R&D laboratories, a cGMP kilo lab, a cGMP pilot plant and multi-ton cGMP manufacturing. Delmar offers a full range of development and manufacturing services including cGMP custom synthesis from gram to multi-ton quantities, analytical method development and validation, process development and validation, ICH stability studies and complete regulatory documentation including the preparation of CMC sections and Drug Master Files in CTD format.
DELORBIS Pharmaceuticals Ltd is a leading generic pharmaceutical company based in Cyprus, Europe. At DELORBIS, we are dedicated to offer: • A broad portfolio of EU Approved Branded Generics, and • Contract Manufacturing & QC Services - flexible, fast & reliable production. Learn more about us at www.delorbispharma.eu
Delpharm is in the top 5 of the European CDMO, committed to delivering high quality products and services since 30 years. Delpharm produces most dosage forms in 12 productions sites located in France, Italy and Belgium. With more than 3200 people working in the company, Delpharm has a turnover of 500 Million Euros. Delpharm devotes annually 30 to 40 Million Euros to investments and innovative solutions.
Demo SA specializes in the research, development, manufacturing and marketing of finished generic pharmaceutical products mainly for hospital use. Demo SA has a wide portfolio of products as injectable antibiotics (cephalosporins, quinolones etc), standard IV solutions of large and small volume (as Sodium Chloride, Dextrose, Ringers Lactate, Water for Injection) antiemetics, sedatives etc. Demo SA is looking for suitable partners in Europe and outside Europe for the distribution and marketing of its products. Demo SA' objectives is the approval and marketing of its hospital products on a paneuropean level.
The Department for International Trade is the UK Government department responsible for promoting British trade across the world. We provide operational support for exports as well as facilitating inward and outward investment. Visit stand 9J40 to learn more on UK capability in the chemical and pharmaceutical manufacturing sector.
Depew Fine Chemical Co Ltd is a company specialized in the marketing, R&D, and manufacturing of Active Pharmaceutical Ingredients, intermediates and fine chemicals, with full experience on the pharmaceutical business and have good relations with many domestic chemical and pharmaceuticals factories. Our strategy is to keep providing better products & services to our clients. We are willing to co-operate with partners sincerely on the basis of mutual benefit and development.
Footskin? Dermatonics of Cambridge UK produces innovative, modern, a highly effective range for treatment of dry skin, fungal nails, warts & Verrucae including vegan and vegetarian options. Incorporating science and natural ingredients sourced globally. Ultraveen range treats Eczema, Psoriasis, Lichen Sclerosis, etc combining urea and oatmeal with impressive outcomes. Listed with Alliance Boots
With 58 establishments and 9300 jobs, the Centre Loire Valley region is one of France's leading regions for the production of medicines. The region's sectoral fabric is made up of big pharmas, foreign laboratories, LFIs (Independent French Laboratories), contractors, research and training centres. Since 2002, with so many major French and international pharmaceutical companies long established within its borders and a high value-added range of know-how and skills to its credit, it has been home to Polepharma, bringing together a wide-reaching network of local SMEs and large specialised groups in a shared-work dynamic.
DEV'UP's objective is to highlight the economic attractiveness of the Centre-Loire valley region. To this end, many activities are carried out all year round - prospecting missions, participation in many promotional events in France and abroad, welcoming potential investors, advertising campaigns, etc.
Deva Holding, established in 1958, is one of the leading pharmaceutical companies in Turkey with EU GMP certified manufacturing facilities, 2000 employees, more than 300 molecules in over 600 different dosage form in Turkish Pharma market and with excellent manufacturing capabilities for nearly all kind of pharmaceutical forms.
Deva develops, produces, markets and sells its high quality finished products, APIs and animal health products worldwide.
Deva offers a wide range of products in antibacterial, antineoplastic, musculoskeletal, cardiovascular, gastrointestinal, respiratory, central nervous system, dermatology and hormones. Deva is constantly seeking to extend its international activities through its partners by license & supply agreements, contract manufacturing, and strategic alliances.
The company's R&D activities are conducted at dedicated laboratories, certified as R&D center in May 2010, with its 150 researchers. Its certified EU-GMP starts with product research and development and covers all processes from production to distribution networks to meet international quality and compliance standards. Deva Holding also has a dedicated and experienced team of specialists in its International Markets Regulatory Affairs Department who contribute to Deva's continuous success by preparing and submitting products dossiers according to country specific regulations.
DFE Pharma is the global leader in excipient solutions. We develop, produce and market excipients for oral solid dose and dry powder inhalation. Our portfolio consists of filler/binders (Lactose, MCC, Starch), Superdisintegrants (CCS and SSG) and carriers for inhalation (Lactose). Please visit www.dfepharma.com
We are a leading manufacturer of Cephalosporin Antibiotics in India with a capacity of 100MTPA of Cephalosporins, exported worldwide to more than 20 countries. Our Company holds the COFEPRIS issued by MEXICO authority for our flagship product. The company is in the process of filing several other product registrations across China, Japan and Europe. We have several technical tie-ups for technology transfer with major manufacturers across the world. Our strengths lie in custom synthesis, R&D, Scale-up and Commercialization of new products. Our current commercial products are: Cefixime, Cefdinir, Cefaclor, Cefuroxime Axetil, Cefpodoxime Proxetil, Cefditoren Pivoxil, Ceftibuten, Cefprozil, Cefcapene, Ceftamet Pivoxil 7AVCA, 7ACCA, Cefuroxime Acid, Cefpodoxime Acid
Di Renzo Regulatory Affairs is an Italian company providing regulatory consulting services in the field of medicines for human and veterinary use, medical devices, biocides, food supplements and cosmetics. The company has a large staff of technical experts and is based in Rome with a branch office in Milan.
Digital Specialty Chemicals (DSC), based in Toronto, Canada, develops
and manufactures high-quality organophosphorus and organometallic chemicals for
the pharmaceutical, specialty chemical and electronic-materials markets. DSC's product
line includes phosphine ligands (including Buchwalds) for homogeneous
catalysis, phosphorylating reagents and challenging organometallics, available
from kilogram to metric ton quantities. DSC offers custom manufacturing
services, with focus on air, moisture and heat sensitives. Through practicing
‘The Chemistry of Excellence', every employee at DSC partners to deliver, new
thoughts, breakthroughs and new solutions to meet development milestones and
produce materials at the highest possible purity on a consistent, repeatable
basis. WE MAKE CHEMISTRY MATTER
Dipharma is one of the leading European manufacturers of Active Pharmaceutical Ingredients, offering about 50 APIs with DMFs lodged worldwide. All three manufacturing sites have been successfully inspected by the European and US Authorities. A fully-equipped R&D Centre, supported by internal Intellectual Property department, develops innovative processes and crystalline forms. One dedicated pilot plant, one small production plant and suitable scale-up facilities make Dipharma the right partner for Custom Synthesis. Core technologies are: Nitration, Nitroesterfication, Complex Hydrogenations, Azidation, Chiral Synthesis, Organometallic, Grignard and Enzimatic chemistry.
DISCH is a leading player in the European market regarding development and contract manufacturing of pharmaceuticals, medical devices and food supplements based on technologies developed in the confectionery industry.
At DISCH, we have been manufacturing sugar based products for over 100 years and
since 2003 DISCH has focused mainly on pharmaceutical products. The manufacturing of
pharmaceuticals and medical devices now makes up to around 80% of the activities.
With an increasing focus on the growing demands of the pharmaceutical industry, we are
continuously upgrading our technological and organizational structures in order to meet the
high standards of our customer's needs as well as the requirements by the authorities.
As a privately owned company our way of thinking and doing business is oriented towards
the long term. It is our goal to continue developing the company for the benefit of all involved
parties in order to offer the highest possible degree of quality, safety and continuity.
Dishman is the global outsourcing partner for the pharmaceutical industry offering a portfolio of development, scale-up and manufacturing services.
The products and services offered span customers' needs from chemical development to commercial manufacture and supply of active pharmaceutical ingredients.
Dishman has a relationship driven business model that improves its customers businesses by providing a range of solutions at locations in Europe, China and India.
"Dishman Group" is not a separate legal entity but nomenclature used in generality for Dishman Pharmaceuticals and Chemicals Limited, the flagship Company, and its Indian and foreign subsidiaries, joint ventures and associate companies across the globe. All these entities are individual and separate by the law.
Dishman is a global, dynamic group of companies offering a continuum of services to the pharmaceutical industry. We are a global outsourcing partner for pharmaceutical companies, offering a portfolio of products and development, scale-up and manufacturing services.
The Dishman Group continually invests in the pharmaceutical industry, ensuring Dishman's businesses can provide pharmaceutical customers with high-value, high-quality products and services today and in the future.
Our focus is to add value to the global pharmaceutical industry by serving as a reliable partner. Our business is successful only when our customers are successful.
Download our corporate brochure here.
DISPROQUIMA is a group with presence on four continents and a high degree of expertise in distribution, marketing and product development, services and solutions to the world of “LIFE SCIENCES”. We deal with reliable and well known suppliers worldwide with appropriate quality standards which allow us to offer a wide range of products to our customers: APIs duly documented (DMF/COS; GMPs; WC…), excipients for different uses (direct compression, Orodispersable dosage forms, effervescent, etc…), functional ingredients, commodities and additives. The 9000m2 facilities make our central premises able to provide warehouses specific for temperature-controlled products, flammable products and health care products. Besides, Disproquima has at your disposal 11 logistic bases complying with GMP/GDP standards. A dedicated sales team will help you in any of the 11 countries where we are present, offering a deep technical knowledge and extensive expertise in their markets. We welcome you to contact us, we'll be glad to offer you A WORLD OF POSSIBILITIES
We develop range of Semi-finished formulations and finished formulations in our ISO 9001 and GMP approved manufacturing facilities. With our strong R&D focus, competency to generate intellectual property and extensive experience in development and manufacturing of modified release formulations, we enjoy the trust of customers in more than ten countries in the Middle-East, CIS, Latin America, Africa and South-East Asia.
Divasa-Farmavic,S.A. is one of the few EU veterinary manufacturers with fully GMP approved facilities to manufacture: >Beta-lactam and non-beta-lactam totally separate production lines for injections/solids: Sterile Solutions, aseptic and terminal sterilization. Sterile Suspensions. Extemporaneous powder for injections. Oral Soluble Powders. Medicated Premixes. >Aerosols >Pets collars >Oral and topic solutions
Limited is a globally recognized pharmaceutical company. Divis has an
overwhelming track record as a dependable supplier of APIs and
custom manufacturer for the big pharma for nearly two decades.
Divi's manufacturing sites had successful audits by USFDA, KFDA, BGV-Hamburg, PMDA-Japan and JAZMP-Slovenia. Unmatched infrastructure: Divis has 4 R&D centres manned by 325 scientists; 2 manufacturing sites with scale up facilities, kilo lab and pilot plants; 32 production buildings with 48 pharma suites; 1055 reactors with total capacity of 7851m3. Certifications: ISO9001; ISO14001; OSHAS18001; FSSC22000. Drug Master Files: USDMF-39; CoS-17; PRMf-24; ASMF-250; KDMF-11; PMDAMF-7
DNS Fine Chemicals is engaged in manufacturing and export of fine chemicals for a variety of industrial requirements. With roots that go as far back as 10 years, it has grown into a highly- matured and experienced company. These industrial chemicals are used in a number of applications in pharmaceutical sector, agricultural sector, food and beverages sector, paper, textiles etc.
We are REACH registered for some of our products. We are also approaching for US FDA WHO. For more information about our products, please visit our website: www.dnsexportsindia.com and www.iodinederivatives.com.
Doctor Pack is a trusted Packaging and Device partner to leading global healthcare, pharmaceutical, diagnostics companies, hospitals, retail pharmacies and contract packagers.
We specialize in design, develop and manufacture of primary packaging, drug delivery system, medical devices, customised plastics components. The special emphasis is given to enhanced patient friendly and child safety. Besides other benefits our innovations focus on making the products affordable in healthcare dispensing systems, Medical Devices, Primary packaging, diagnostic devices such as Lancing Devices, Need safe system, vials and closures for over-the-counter and prescription drugs.
We drive innovation and product performance for the pharmaceutical industry with advanced drug delivery systems for applications including:
Ophthalmic Delivery System
Parenteral Delivery Devices
Nasal Delivery System
Inhalation Delivery System
Oral Delivery System
Diabetes Delivery Devices
Doctor Pack is more than just a packaging company. We provide comprehensive support to your product's lifecycle from innovation through commercialization via patient-centered delivery solutions.
To strengthen and grow our Leadership Position in Pharma and Health Care Packaging by providing Prompt, Innovative, Cost Effective and Aesthetically Superior Packaging, Drug Delivery System, Medical Devices, developed and manufactured in compliance with cGMP standards.
We exist to create Benefit and Value to our Internal & External Customers.
Continue to be the pioneer in introducing Innovative Products, adopting the Latest Technology, Materials, cGMP and the Global Standards.
In next 5 years we want to be one of the top 10 global Pharma packaging and Drug Delivery System Company with plants around the Globe.
We want to be the Globally Preferred “Perfect Packaging & Innovative Device Partner” who provides innovative, cost effective Solutions.
We are committed to “The Total Customer Satisfaction” by:
Delivering the best to our customers in terms of products, services and economics by strictly adhering to the international standards and systems being adopted by us.
Implementing and sustaining current Good Manufacturing Practices at all level.
Striving for continual improvement in the respective areas of innovation, product quality Production processes, Training, On Time Delivery, Waste reduction etc.
Environment Management System
We are fully committed to prevent all forms of Pollution and provide Safe and Healthy Environment to all our Business partners including Customers, Suppliers, Employees, Society, and Government Body etc.
Our EMS Policy is to:
Fully comply with the requirements of current environmental legislation and EMS.
Minimize our waste by ensuring the most efficient operation.
Minimize Energy and Water usage by adopting the latest Energy Efficient Technology.
Apply the principles of continuous improvement with respect to air, water and noise pollution from our operations.
Ensure that all employees understand, adhere and contribute to our environmental policy by motivation and providing regular training.
Promote Green Revolution by planting more Trees and aim for paper free office.
Dokumeds is mid-size CRO with 10 registered offices across Europe and Russia, operating globally, together with strategic partners. We are trusted partner for pharmaceutical and biotech companies, managing phase I–IV clinical trials. Dokumeds strength is our professional and dedicated team who will execute your project smoothly, reach recruitment targets, and ensure quality-focused oversight.
Domaco Dr. med. Aufdermaur AG, Switzerland. Domaco pharma is a new division within the Domaco Group. Specialised for high quality products with active pharmaceutical ingredients and therapeutic plants. Full service: research and development, consultancy and conception, manufacturing, packaging, project management, compiling dossiers for pharmaceutical projects. Quality standards: ISO 9001:2008, BRC grade A, IFS higher Level, GMP Swissmedics, organic. Technologies: instantizing, moulding, pressing, casting. Dr. med. Aufdermaur AG, Pharmaceutical Division, Weststrasse 16, CH-5426 Lengnau, Switzerland. Phone: +41 56 266 5521. Contact: [email protected] Visit www.domaco-pharma.com.
Dong-A has been the largest pharmaceutical company in Korea since 1967. We have solidified our leading market position on the strength of in-house developed products such as Suganon tab. Evogliptin, the DPP-4 inhibitor for type 2 diabetes mellitus, Zydena tab. Udenafil, the fourth PDE5 inhibitor in the world for erectile dysfunction, Stillen tab. Eupatilin for herbal treatment of gastritis and Motilitone tab. Corydaline for functional dyspepsia. Furthermore, we are offering branded generic drugs (anti-cancer, anti-TB, etc.), bio-pharmaceutical, IMD, APIs and OTC products ensuring full compliance to international quality standard. Currently Dong-A is exporting its products to more than 50 countries to leading pharmaceutical companies in Europe, Latin America and Asia.
Since 1970, DongKoo Bio&Pharma Co., Ltd has been evolving into a global healthcare leader.
DongKoo Bio&Pharma, consolidated with world-class research centers and PIC/s fulfilled GMP facilities, has been No.1 in Korean dermatology prescription market. DongKoo Bio&Pharm is also in vigor expansion of its commercial territories to global markets in the field of generic drugs and contract manufacturing. The company is also growing its influence in stem cell technology, developing world 1st SVF extraction kit (SMART X) and stem cell conditioned media cosmeceutical (CELL BLOOM).
With synergy between bio technology (stem cell technology) and pharmaceutical, DongKoo Bio&Pharma pursues a total healthcare solution that contributes in improving people's quality of life
Dongkook Pharmaceutical was founded in 1968 and since its foundation, Dongkook has concentrated on R&D and technology innovation. Dongkook is well known for OTC products of high brand values in Korea. Additionally, Dongkook has developed and produced outstanding therapeutic products including anesthetics, contrast media and anti-cancer agents. Dongkook has been recognized by domestic and foreign authorities for its quality of finished products, medical devices and APIs. Currently, Dongkook exports the finished products, medical devices and APIs to over 50 countries around the world, and seeks to grow into a global leading pharmaceutical company.
Jiangsu Dongtai Xinyuan Chemical Co Ltd is a joint enterprise specialized in research, development and production of fine chemicals. Xinyuan was located in Pudong, Shanghai, and moved to Dongtai Chemical Zone of Jiangsu province in 2003. Meeting the requirement of our customers, Xinyuan has enjoyed a good reputation in its skilful management and R & D team, advanced production equipments and good QA & QC system. With its several years of development, Xinyuan now can provide over 30 fine chemical products widely applied in different fields including pharmaceuticals, pesticide and dyestuff etc. Its customers are from Europe, USA, Japan and Korea. With its faithful, efficient and specialized service, Xinyuan is looking forward to cooperating with the customers to get a win-win result.
DONGWHA PHARM, the first established pharmaceutical company in Korea founded in 1897, has been engaged in development, production, distribution and marketing of ethical drugs including solid dosage formulations and sterile injectables, APIs, over-the-counter drugs, food supplements, healthcare products, and cosmetics. With a goal to become a global hub for drug development, DONGWHA PHARM has been contributing to human health and well-being worldwide through innovative drug discovery, and global commercialization, driven by the state-of-the-art facilities and the research center. DONGWHA Research Institute has provided the foundation for development of high quality medicines and innovative NCE, such as Zabofloxacin. Furthermore, it continues to conduct research and studies for the development of innovative new drug, drug repositioning, botanical drug, and IMD. DONGWHA PHARM has been in the business of good health and wellness across three centuries building up a wide range of quality brands to improve the quality of life. DONGWHA PHARM is strengthening its presence both in domestic and overseas markets from actively expanding the domestic sales & marketing, licensing In/Out, exporting API and finished products to the countries around the world.
Tiandong Biopharmaceutical Company has been focusing on manufacturing of polysaccharide products since its foundation in 1992. There are two API workshops and one new injection workshop. APIs include Enoxaparin sodium (annual capacity 2500kg), heparin sodium and heparin calcium (annual capacity 1,500,000 mega IU), Nadroparin calcium, Dalteparin sodium and Parnaparin sodium. The injection workshop with an annual capacity of 21 million units has been built as per US FDA guidelines.
Novolite Chemicals Co Ltd is a high tech enterprise that was established by a group of reputable professors and doctors in 2002. Our aim is to have our update research come into the real industrial scale production to support our customer's drug development program. We established our technical research and develop base on Shanghai China East University of Science and Engineering, and established our producing facility in Wujiang and Zhangjiagang, Jiangshu, which is built under GMP requirement of Pharmaceutical industry. Every day, every dedicated employee in Novolite is focused to satisfy our customers. Biochemistry, chemistry, and their related technologies form our core competencies and it is our pleasure to introduce these to you.
With more than 20 years of expertise and knowledge
in the field, Doosan Corporation offers premium quality of natural
phospholipids for pharmaceutical, cosmetic and food applications. Either to strengthen emulsion properties, stabilize
the formulation or design the liposomal delivery, end user can choose Doosan's
phospholipids based on its origin (egg yolk, soybean, milk, sunflower) or
phosphatidylcholine at particular contents to fine tune the final applications.
Additionally, functional food ingredients, Phosphatidylserine series, known to
enhance brain memories and cosmetic ingredients, Ceramide and Hydroceramide, benefiting
skin in retaining water and fight aging, are also available.
is a contract development and manufacturing organization (CDMO). Headquartered
in Italy with two state-of-the-art finished dosage
forms manufacturing sites, the Company offers a full range of
manufacturing and packaging services for its national and
Through its highly advanced R&D labs and pilot scale facilities, Doppel can provide with customized product and process development (which range from pre-formulation to industrial scale production), including manufacturing of IMP batches, regulatory support and CTD drafting services.
Dorizoe Lifesciences Ltd is a purely Contract Research & Finished Product Development Organization based in India, working for Pharmaceutical Companies operating in Regulated Markets. We have strong capability in Finished Product Development of Parentral, Injectable (Lyophilized to Aqueous in Cytotoxic and Non Cytotoxic space) & Semi-Solids Like Creams, ointments & Gel in different delivery systems including Ampoules, Vials, PFS, PVC and Non - PVC bags and so on. At Dorizoe, we have very strong capability of developing injectables in cytotoxic to non cytotoxic space in lyophilized to aqueous form. After developing the product, we can also assist you for contract manufacturing by transferring the technology to your preferred CMO or at our recommended / preferred CMO partners. Apart from contract development, we also provide the Customized Services of Formulation and Development, Analytical Service, Quality Assurance, Regulatory Services and other Pharmaceutical Support Services. Currently we are working with the top pharmaceutical company of the world and providing services for parenteral development as well as technology transfer for their injectable products.
Apart from contract product development, we are also working on in our in house development projects whereby we will be developing the product till TTDs(Technology Transfer Dossiers) and out licensing readily available TTDs to our prospective clients in global market place. For these TTDs, we will also assist our client for tech transfer to their preferred CMO.
Dott. Bonapace & C is a worldwide and well-known Italian manufacturer of lab-scale equipment for pharmaceutical R&D departments, nutraceutical laboratories, etc. In our equipment range, you can find semi-automatic and fully automatic capsule filling machines, rotary and single punch tablet presses, suppository lines, blistering machines, powder and liquid dosers, etc. Special WIP and isolated applications are also available.
Dow in Switzerland is part of The Dow Chemical Company, a US chemical company. We combine chemistry and innovation with the principles of sustainability, to address world challenges.
Our diversified industry-leading portfolio of specialty chemicals, advanced materials, agrosciences and plastics businesses delivers a broad range of technology-based products and solutions to customers in approximately 180 countries and in high growth sectors such as electronics, water, energy, coatings and agriculture.
Dow Corning is a major supplier of silicon-based raw materials, excipients and APIs, serving the entire spectrum of the pharmaceutical industry. We have over 60 years of experience in healthcare-related industries and unify pioneering research with decades of market, regulatory and cGMP production experience to help customers accelerate product development, reduce time to market and create value. With expertise in topical, transdermal and oral routes of delivery, fluid transportation and process aids, Dow Corning provides innovative silicon-based materials with proven performance to be able to quickly and successfully produce and deliver actives with outstanding safety, efficacy and patient compliance.
DPT, a Mylan company, is a leading contract development and manufacturing organization, recognized for its excellence in semi-solid and liquid dosage forms. Founded in 1938, DPT provides the best development and manufacturing solutions for our customers. Backed by a team of approximately 1,000 employees in San Antonio, Texas, DPT has unmatched experience, resources and capacity to efficiently serve your pharmaceutical development and manufacturing needs –no matter the scope.
From concept to commercialization, DPT remains committed to exceeding expectations for quality and service. No other company offers a 75-plus year history of stability, superior technical expertise and regulatory merit in semi-solids and liquids.
Your excellent partner for Contract Manufacturing of lozenges! Your choice is our business: we combine your API with our delicious drops. We are one of the few confectioners in Germany which is GMP-certified and also has a licence to manufacture pharmaceuticals and special medical devices. We process orders for leading international pharmaceutical companies, working with a diverse range of active ingredients - whether for hard caramels, soft pastilles, lozenges and gumdrops,
Dr Müller Pharma offers contract production of pharmaceuticals, medical devices, food supplements and cosmetics (non-sterile semi-solid products, suppositories, hard boiled lozenges, batch release and certification, primary and secondary packaging of tablets, capsules, quality control testing, batch release and certification of imported medicinal products. Family company established 1995.